GlassScriptPhysician profile
Dimple K-A Marwaha
NPI 1265495766
$1,878.37
in general payments reported to CMS, 2019-2025
25 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.90 · 2020: $24.57 · 2021: $184 · 2022: $57.60 · 2023: $652 · 2024: $584 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,294 · Travel and Lodging: $258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,293.77 |
| Travel and Lodging | $258.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $453.76 | 2023-2025 | |
| Pfizer INC. | $407.32 | 2019-2025 | |
| Bone Support INC. | $146.48 | 2024 | Ceramentbone Void Filler, Cerament G |
| Organogenesis INC. | $125.00 | 2021 | |
| Glaxosmithkline, LLC. | $100.06 | 2024-2025 | Shingrix, Arexvy |
| Orthofix Medical, INC. | $91.68 | 2022-2024 | Physio-Stim |
| Novo Nordisk INC | $61.38 | 2021-2023 | Wegovy, Ozempic |
| Revance Therapeutics, INC. | $53.98 | 2024 | Daxxify |
| Boehringer Ingelheim Pharmaceuticals, INC. | $51.92 | 2025 | Jardiance |
| Anika Therapeutics, INC. | $50.63 | 2023 | Tactoset, Integrity |
| Inspire Medical Systems, INC. | $38.68 | 2025 | Inspire |
| Vanda Pharmaceuticals INC. | $35.02 | 2025 | Fanapt |
| Nevro Corp. | $34.56 | 2023 | Senza |
| Exact Sciences Corporation | $29.20 | 2025 | The Cologuard Plus Collection Kit |
| Bioventus LLC | $28.66 | 2023 | Exogen Ultrasound Bone Healing System |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.59 | 2021 | |
| Seqirus USA INC | $19.85 | 2024 | Flucelvax, Fluad |
| Qiagen, LLC | $18.57 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $17.89 | 2023 | Jublia |
| Merck Sharp & Dohme LLC | $16.36 | 2022 | |
| Derma Sciences, INC. | $15.88 | 2019 | |
| Hartmann USA, INC. | $15.62 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.05 | 2024 | Spravato |
| Tactile Systems Technology INC | $13.95 | 2019 | |
| Smith+Nephew, INC. | $12.28 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dimple Marwaha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.